Published in Med Pediatr Oncol on January 01, 1985
Metastatic neuroblastoma confined to distant lymph nodes (stage 4N) predicts outcome in patients with stage 4 disease: A study from the International Neuroblastoma Risk Group Database. J Clin Oncol (2014) 0.84
Prognostic value of different staging systems in neuroblastomas and completeness of tumour excision. Arch Dis Child (1986) 0.77
Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma. N Engl J Med (1998) 5.74
Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci U S A (1993) 2.86
BRCA1 inhibition of estrogen receptor signaling in transfected cells. Science (1999) 2.54
A murine model of experimental metastasis to bone and bone marrow. Cancer Res (1988) 2.32
Results of treatment of 127 patients with systemic histiocytosis. Medicine (Baltimore) (1981) 2.17
Radiation induced neoplasia following external beam therapy for children with retinoblastoma. Am J Roentgenol Radium Ther Nucl Med (1969) 1.88
Role of direct interaction in BRCA1 inhibition of estrogen receptor activity. Oncogene (2001) 1.82
Scatter factor/hepatocyte growth factor protects against cytotoxic death in human glioblastoma via phosphatidylinositol 3-kinase- and AKT-dependent pathways. Cancer Res (2000) 1.56
Levels of vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesis. Int J Cancer (1999) 1.52
Expression of interleukin-1beta in human breast carcinoma. Cancer (1997) 1.52
Considerations in the radiation therapy of Wilms' tumor. Cancer (1973) 1.51
Risk of second tumors in survivors of childhood cancer. Cancer (1975) 1.51
Histiocytosis-X. N Engl J Med (1981) 1.51
Expression of scatter factor and c-met receptor in benign and malignant breast tissue. Cancer (1997) 1.50
Alcohol stimulates estrogen receptor signaling in human breast cancer cell lines. Cancer Res (2000) 1.46
Feasibility and toxicity of transrectal ultrasound hyperthermia in the treatment of locally advanced adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys (1993) 1.44
Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia. N Engl J Med (1986) 1.42
Cellular senescence in a cloned strain of bovine fetal aortic endothelial cells. Science (1980) 1.41
Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia. Cancer Res (1983) 1.39
The tumor promoter 12-O-tetradecanoyl-phorbol-13-acetate enhances the proliferative response of Balb/c-3T3 cells to hormonal growth factors. J Cell Physiol (1979) 1.37
Roentgenologic aspects of Hodgkin's disease. II. Role of routine radiographs in detecting initial relapse. Cancer (1973) 1.37
In vitro and in vivo killing of acute lymphoblastic leukemia cells by L-asparaginase. Cancer Res (1989) 1.37
Three-dimensional structure of Fab R19.9, a monoclonal murine antibody specific for the p-azobenzenearsonate group. Proc Natl Acad Sci U S A (1989) 1.35
Complete correction of the Wiskott-Aldrich syndrome by allogeneic bone-marrow transplantation. N Engl J Med (1978) 1.35
The cytokine hepatocyte growth factor/scatter factor inhibits apoptosis and enhances DNA repair by a common mechanism involving signaling through phosphatidyl inositol 3' kinase. Oncogene (2000) 1.31
Radiation therapy for rhabdomyosarcoma of the orbit. Trans Am Acad Ophthalmol Otolaryngol (1969) 1.28
BRCA1 and BRCA2 as molecular targets for phytochemicals indole-3-carbinol and genistein in breast and prostate cancer cells. Br J Cancer (2006) 1.27
Synthesis of human plasminogen by the liver. Science (1980) 1.27
The role of radiotherapy in the treatment of malignant sweat gland neoplasms. Cancer (1990) 1.26
Scatter factor promotes motility of human glioma and neuromicrovascular endothelial cells. Int J Cancer (1998) 1.26
Treatment of plasma cell granuloma of the lung with radiation therapy. A report of two cases and a review of the literature. Cancer (1986) 1.24
Activation of estrogen signaling pathways collaborates with loss of Brca1 to promote development of ERalpha-negative and ERalpha-positive mammary preneoplasia and cancer. Oncogene (2007) 1.24
Definitive radiation therapy of carcinoma of the prostate. A report on 15 years of experience. Radiology (1973) 1.23
Treatment of malignant brain tumors with focused ultrasound hyperthermia and radiation: results of a phase I trial. J Neurooncol (1991) 1.20
Favorable response of metastatic osteogenic sarcoma to pulse high-dose methotrexate with citrovorum rescue and radiation therapy. Cancer (1973) 1.19
BRCA1 as a potential human prostate tumor suppressor: modulation of proliferation, damage responses and expression of cell regulatory proteins. Oncogene (1998) 1.18
Response of avian embryonic brain to spatially segmented x-ray microbeams. Cell Mol Biol (Noisy-le-grand) (2001) 1.15
Incidence and distribution of experimental metastases in mutant mice with defective organ microenvironments (genotypes Sl/Sld and W/Wv). Cancer Res (1992) 1.14
Inhibition of tumor growth and metastasis of human breast cancer cells transfected with tissue inhibitor of metalloproteinase 4. Oncogene (1997) 1.14
The multisubstrate adapter Gab1 regulates hepatocyte growth factor (scatter factor)-c-Met signaling for cell survival and DNA repair. Mol Cell Biol (2001) 1.13
Severe ototoxicity following carboplatin-containing conditioning regimen for autologous marrow transplantation for neuroblastoma. Bone Marrow Transplant (1998) 1.13
Modulation of HGF-induced tubulogenesis and branching by multiple phosphorylation mechanisms. Dev Biol (1993) 1.13
Radiation therapy in retinoblastoma. An analysis of 230 cases. Radiology (1969) 1.12
Constitutive activation of JAK-STAT3 signaling by BRCA1 in human prostate cancer cells. FEBS Lett (2001) 1.12
Relationship of VH and VL genes encoding three idiotypic families of anti-p-azobenzenearsonate antibodies. Proc Natl Acad Sci U S A (1986) 1.11
Tumors of the exocrine pancreas in children and adolescents. A clinical and pathologic study of eight cases. Am J Surg Pathol (1983) 1.11
Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice. Lab Invest (1997) 1.10
Signal transduction in c-met mediated motogenesis. EXS (1993) 1.10
Scatter factor protects epithelial and carcinoma cells against apoptosis induced by DNA-damaging agents. Oncogene (1998) 1.10
Inhibitory effects of Indole-3-carbinol on invasion and migration in human breast cancer cells. Breast Cancer Res Treat (2000) 1.09
Comparison of three methods of central-nervous-system prophylaxis in childhood acute lymphoblastic leukaemia. Lancet (1980) 1.09
Radiation-induced angiosarcoma of the breast. Case report and review of the literature. Am J Clin Oncol (1994) 1.07
Pathogenesis of vertebral metastasis and epidural spinal cord compression. Cancer (1990) 1.06
The "typical" spine changes of sickle-cell anemia in a patient with thalassemia major (Cooley's anemia). Radiology (1967) 1.06
Preliminary clinical experience with linear accelerator-based spinal stereotactic radiosurgery. Neurosurgery (1995) 1.05
Proliferative characteristics of clonal endothelial cell strains. J Cell Physiol (1981) 1.05
Regulation of BRCA1 and BRCA2 expression in human breast cancer cells by DNA-damaging agents. Oncogene (1998) 1.04
Prognostic significance of complete surgical resection of pulmonary metastases in patients with osteogenic sarcoma: analysis of 32 patients. J Clin Oncol (1984) 1.03
Strategies for assessing the implications of malformed frogs for environmental health. Environ Health Perspect (2000) 1.03
Hind limb malformations in free-living northern leopard frogs (Rana pipiens) from Maine, Minnesota, and Vermont suggest multiple etiologies. Teratology (2000) 1.02
Scatter factor/hepatocyte growth factor (SF/HGF) content and function in human gliomas. Int J Dev Neurosci (1999) 1.02
Neuroblastoma: the Joint Center for Radiation Therapy/Dana-Farber Cancer Institute/Children's Hospital experience. J Clin Oncol (1984) 1.01
Role of scatter factor in the pathogenesis of AIDS-related Kaposi sarcoma. Proc Natl Acad Sci U S A (1994) 1.00
Indole-3-carbinol is a negative regulator of estrogen receptor-alpha signaling in human tumor cells. J Nutr (2000) 1.00
Effect of scatter factor and hepatocyte growth factor on motility and morphology of MDCK cells. In Vitro Cell Dev Biol (1992) 1.00
Suppression of breast cancer invasion and migration by indole-3-carbinol: associated with up-regulation of BRCA1 and E-cadherin/catenin complexes. J Mol Med (Berl) (2000) 0.99
Prognosis for children with neuroblastoma presenting with paralysis. J Pediatr Surg (1977) 0.98
Disruption of BRCA1 LXCXE motif alters BRCA1 functional activity and regulation of RB family but not RB protein binding. Oncogene (2001) 0.98
Phosphoinositide 3-hydroxide kinase blockade enhances apoptosis in the Ewing's sarcoma family of tumors. Cancer Res (1999) 0.97
Radiation therapy in patients with histiocytosis: management of diabetes insipidus and bone lesions. Int J Radiat Oncol Biol Phys (1979) 0.97
A pilot study of tandem high-dose chemotherapy with stem cell rescue as consolidation for high-risk neuroblastoma: Children's Oncology Group study ANBL00P1. Bone Marrow Transplant (2013) 0.97
External beam radiotherapy and hyperthermia in the treatment of patients with locally advanced prostate carcinoma. Cancer (2000) 0.96
A chimeric mouse-human antibody that retains specificity for HIV gp120 and mediates the lysis of HIV-infected cells. J Immunol (1989) 0.96
Second neoplasms after Wilms' tumor in childhood. J Natl Cancer Inst (1983) 0.95
An evaluation of long-term survival and treatment complications in children with Hodgkin's disease. Cancer (1983) 0.95
Medulloblastoma at the joint center for radiation therapy between 1968 and 1984. The influence of radiation dose on the patterns of failure and survival. Cancer (1988) 0.95
Tolerance of brain to multiple courses of radiation therapy. I. Clinical experiences. Br J Radiol (1981) 0.94
Radiation therapy in the treatment of aggressive fibromatoses. Int J Radiat Oncol Biol Phys (1981) 0.94
Expression of scatter factor in human bladder carcinoma. J Natl Cancer Inst (1995) 0.94
Scatter factor binds to thrombospondin and other extracellular matrix components. Am J Pathol (1996) 0.94
Esophagitis due to adriamycin and radiation therapy for childhood malignancy. Cancer (1978) 0.94
Primary lymphomas of the central nervous system: patterns of failure and factors that influence survival. J Clin Oncol (1985) 0.94
High-dose methotrexate with citrovorum factor in osteogenic sarcoma--progress report II. Cancer Treat Rep (1977) 0.93
Improved outlook for Ewing's sarcoma with combination chemotherapy (vincristine, actinomycin D and cyclophosphamide) and radiation therapy. Cancer (1976) 0.92
The role of radiation therapy in the treatment of pediatric non-Hodgkin's lymphomas. Cancer (1978) 0.92
Prophylactic subconjunctival antibiotics following cataract extraction. Am J Ophthalmol (1967) 0.92
In vitro versus in vivo metabolic activation of mutagens. Environ Health Perspect (1973) 0.92
Primary lymphoma of bone in children: analysis of treatment results with adriamycin, prednisone, Oncovin (APO), and local radiation therapy. J Clin Oncol (1986) 0.92
Late recurrence in endometrial carcinoma. Cancer (1987) 0.91
Improved prognosis for patients with mediastinal lymphoblastic lymphoma. Blood (1979) 0.91
Ultraviolet radiation down-regulates expression of the cell-cycle inhibitor p21WAF1/CIP1 in human cancer cells independently of p53. Int J Radiat Biol (1999) 0.91
Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells. Cancer Res (2001) 0.91
Stimulation of cell invasion and migration by alcohol in breast cancer cells. Biochem Biophys Res Commun (2000) 0.91
Altered gene expression pattern in cultured human breast cancer cells treated with hepatocyte growth factor/scatter factor in the setting of DNA damage. Cancer Res (2001) 0.91